AJTMH HINARI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am. J. Trop. Med. Hyg., 40(5), 1989, pp. 455-464
Copyright © 1989 by The American Society of Tropical Medicine and Hygiene

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Collins, W. E.
Right arrow Articles by Wilson, C. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Collins, W. E.
Right arrow Articles by Wilson, C. L.

Immunization of Saimiri Sciureus Boliviensis with Recombinant Vaccines Based on the Circumsporozoite Protein of Plasmodium Vivax

William E. Collins, Ruth S. Nussenzweig, W. Ripley Ballou, Trenton K. Ruebush, II, Elizabeth H. Nardin, Jeffrey D. Chulay, William R. Majarian, James F. Young, Gail F. Wasserman, Ian Bathurst, Helen L. Gibson, Philip J. Barr, Stephen L. Hoffman, Steven S. Wasserman, J. Roger Broderson, Jimmie C. Skinner, Patricia M. Procell, Valerie K. Filipski AND Carla L. Wilson
Centers for Disease Control, Atlanta, Georgia; New York University Medical Center, New York, New York; Walter Reed Army Institute of Research, Washington, DC; Smith Kline and French Laboratories, Swedeland, Pennsylvania; Chiron Corporation, Emeryville, California; Naval Medical Research Institute, Bethesda, Maryland; and University of Maryland School of Medicine, Baltimore, Maryland

We report a trial in squirrel monkeys of 2 recombinant Plasmodium vivax malaria vaccine candidates based on the circumsporozoite (CS) protein. One recombinant (NSI81 V20), produced in Escherichia coli, contains the repeat region of the CS protein. The other (VIVAX-1) recombinant is yeast-derived and contains the entire repeat domain and part of the surrounding N-terminal and C-terminal regions. Both antigens were administered with alum and muramyl tripeptide as adjuvants. No formulations caused toxic side effects. Both antigens, when administered with alum, induced high levels of sporozoite antibodies in all animals. Another group of animals was immunized with irradiated sporozoites alone. Upon challenge, a few immunized animals did not develop detectable parasitemia and others developed parasitemia only after a prolonged prepatent period. Monkeys immunized with irradiated sporozoites had higher levels of antibody but no increased protection. There was no correlation between protection and either antibody level or the in vitro proliferation of lymphocytes in response to the antigens. This is the first time P. vivax sporozoite vaccines have been tested in monkeys with a subsequent sporozoite challenge.




This article has been cited by other articles:


Home page
 Am J Trop Med HygHome page
W. R. Ballou and C. P. Cahill
Two Decades of Commitment to Malaria Vaccine Development: GlaxoSmithKline Biologicals
Am J Trop Med Hyg, December 1, 2007; 77(6_Suppl): 289 - 295.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
A. Yadava, J. Sattabongkot, M. A. Washington, L. A. Ware, V. Majam, H. Zheng, S. Kumar, and C. F. Ockenhouse
A Novel Chimeric Plasmodium vivax Circumsporozoite Protein Induces Biologically Functional Antibodies That Recognize both VK210 and VK247 Sporozoites
Infect. Immun., March 1, 2007; 75(3): 1177 - 1185.
[Abstract] [Full Text] [PDF]

Home page
 Am J Trop Med HygHome page
W. E. COLLINS, J. S. SULLIVAN, A. WILLIAMS, D. NACE, T. WILLIAMS, G. G. GALLAND, and J. W. BARNWELL
Aotus nancymaae as a potential model for the testing of anti-sporozoite and liver stage vaccines against Plasmodium falciparum.
Am J Trop Med Hyg, March 1, 2006; 74(3): 422 - 424.
[Abstract] [Full Text] [PDF]

Home page
 ScienceHome page
Y Charoenvit, W. Collins, T. Jones, P Millet, L Yuan, G. Campbell, R. Beaudoin, Broderson JR, and S. Hoffman
Inability of malaria vaccine to induce antibodies to a protective epitope within its sequence
Science, February 8, 1991; 251(4994): 668 - 671.
[Abstract] [PDF]

Home page
 ScienceHome page
R Rosenberg, R. Wirtz, D. Lanar, J Sattabongkot, T Hall, A. Waters, and C Prasittisuk
Circumsporozoite protein heterogeneity in the human malaria parasite Plasmodium vivax
Science, September 1, 1989; 245(4921): 973 - 976.
[Abstract] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1989 by the American Society of Tropical Medicine and Hygiene.